Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Behavioral Effects of Drugs Inpatient 44: Neurobehavioral Mechanisms of Opioid Choice

NCT06312657 is registered in ClinicalTrials.gov with Joshua A. Lile, Ph.D. as lead sponsor.

NCT NCT06312657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06312657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Behavioral Effects of Drugs Inpatient 44: Neurobehavioral Mechanisms of Opioid Choice
Lead sponsor
Joshua A. Lile, Ph.D.
Phase
Phase 1
Overall status
Terminated
Start date
March 1, 2023
Completion date
March 28, 2025
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder